^
over3years
Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer. (PubMed, Mol Cancer Ther)
Additionally, the use of Didox was also found to ameliorate the toxic myocardial effects of doxorubicin in vivo as measured by heart mass, left ventricular diameter, and serum troponin T levels. The data present a novel and promising approach for the treatment of TNBC that merits further clinical evaluation in humans.
Journal
|
ER (Estrogen receptor) • TP53 (Tumor protein P53) • RRM2 (Ribonucleotide Reductase Regulatory Subunit M2)
|
TP53 mutation • ER positive • ER negative
|
doxorubicin hydrochloride • didox (NSC-324360) • Furtulon (doxifluridine)
over3years
Doxifluridine-based pharmacosomes delivering miR-122 as tumor microenvironments-activated nanoplatforms for synergistic treatment of hepatocellular carcinoma. (PubMed, Colloids Surf B Biointerfaces)
The integrated nanosystem (p122-ap1@NPC-D) was found to unleash by programmed TMEs (high level of HO and low pH) to efficiently transfect miR-122 into MHCC-LM3 cells, followed by the releases of 5-FU. Besides, p122-ap1@NPC-D significantly countered the chemotherapy resistance and played a synergistic effect. These unique nanoparticles dramatically enhanced the anti-proliferation, and modulated the cellular apoptosis by the down-regulation of various signal pathways which imparted a bright application prospect in HCC treatment.
Journal
|
EPCAM (Epithelial cell adhesion molecule)
|
fluorouracil topical • Furtulon (doxifluridine)
almost4years
Radiation-Associated Angiosarcoma That Developed in the Irradiated Residual Breast after Breast-Conserving Surgery for Breast Cancer-A Case Report and Review of the Literature (PubMed, Gan To Kagaku Ryoho)
A7 2-year-old woman had undergone BCS for invasive ductal carcinoma of the right breast(pT2pN1M0, StageⅡB), followed by RT of 50 Gy; she was treated with doxifluridine and anastrozole for 5 year. RAAS is rare, but it should be considered in patients with skin lesions, such as erosion and bloody bulla, after BCS and RT for breast cancer. To our knowledge, only 12 cases of RAAS, including the present case, have been reported in Japan, and we reviewed the Japanese RAAS cases in comparison with those reported in the Western literature.
Clinical • Review • Journal
|
VEGFA (Vascular endothelial growth factor A) • CD34 (CD34 molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1)
|
anastrozole • Furtulon (doxifluridine)